{"title":"“从肿瘤相关抗原衍生的多表位候选疫苗的阳离子胶束递送,导致小鼠已建立的CT26结直肠肿瘤的消退”的更正。","authors":"","doi":"10.1002/jbm.a.37810","DOIUrl":null,"url":null,"abstract":"<p>F. Sabzehei, A. H. Taromchi, A. Ramazani, et al., “Cationic Micelle Delivery of a Multi-Epitope Vaccine Candidate Derived From Tumor-Associated Antigens, Causing Regression in Established CT26 Colorectal Tumors in Mice,” <i>Journal of Biomedical Materials Research Part A</i> 112, no. 5 (2024): 733–742, https://doi.org/10.1002/jbm.a.37654.</p><p>We state here that, the animal approval statement was removed by mistake from the published article and that the ethics approval statement should read as follows:</p><p>The research was approved by the Ethics Committee, Zanjan University of Medical Sciences (Approved Number: IR.ZUMS.REC.1398.034).</p><p>We apologize for these errors.</p>","PeriodicalId":15142,"journal":{"name":"Journal of biomedical materials research. Part A","volume":"113 1","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jbm.a.37810","citationCount":"0","resultStr":"{\"title\":\"Erratum to “Cationic Micelle Delivery of a Multi-Epitope Vaccine Candidate Derived From Tumor-Associated Antigens, Causing Regression in Established CT26 Colorectal Tumors in Mice”\",\"authors\":\"\",\"doi\":\"10.1002/jbm.a.37810\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>F. Sabzehei, A. H. Taromchi, A. Ramazani, et al., “Cationic Micelle Delivery of a Multi-Epitope Vaccine Candidate Derived From Tumor-Associated Antigens, Causing Regression in Established CT26 Colorectal Tumors in Mice,” <i>Journal of Biomedical Materials Research Part A</i> 112, no. 5 (2024): 733–742, https://doi.org/10.1002/jbm.a.37654.</p><p>We state here that, the animal approval statement was removed by mistake from the published article and that the ethics approval statement should read as follows:</p><p>The research was approved by the Ethics Committee, Zanjan University of Medical Sciences (Approved Number: IR.ZUMS.REC.1398.034).</p><p>We apologize for these errors.</p>\",\"PeriodicalId\":15142,\"journal\":{\"name\":\"Journal of biomedical materials research. Part A\",\"volume\":\"113 1\",\"pages\":\"\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-01-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jbm.a.37810\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of biomedical materials research. Part A\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jbm.a.37810\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical materials research. Part A","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jbm.a.37810","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Erratum to “Cationic Micelle Delivery of a Multi-Epitope Vaccine Candidate Derived From Tumor-Associated Antigens, Causing Regression in Established CT26 Colorectal Tumors in Mice”
F. Sabzehei, A. H. Taromchi, A. Ramazani, et al., “Cationic Micelle Delivery of a Multi-Epitope Vaccine Candidate Derived From Tumor-Associated Antigens, Causing Regression in Established CT26 Colorectal Tumors in Mice,” Journal of Biomedical Materials Research Part A 112, no. 5 (2024): 733–742, https://doi.org/10.1002/jbm.a.37654.
We state here that, the animal approval statement was removed by mistake from the published article and that the ethics approval statement should read as follows:
The research was approved by the Ethics Committee, Zanjan University of Medical Sciences (Approved Number: IR.ZUMS.REC.1398.034).
期刊介绍:
The Journal of Biomedical Materials Research Part A is an international, interdisciplinary, English-language publication of original contributions concerning studies of the preparation, performance, and evaluation of biomaterials; the chemical, physical, toxicological, and mechanical behavior of materials in physiological environments; and the response of blood and tissues to biomaterials. The Journal publishes peer-reviewed articles on all relevant biomaterial topics including the science and technology of alloys,polymers, ceramics, and reprocessed animal and human tissues in surgery,dentistry, artificial organs, and other medical devices. The Journal also publishes articles in interdisciplinary areas such as tissue engineering and controlled release technology where biomaterials play a significant role in the performance of the medical device.
The Journal of Biomedical Materials Research is the official journal of the Society for Biomaterials (USA), the Japanese Society for Biomaterials, the Australasian Society for Biomaterials, and the Korean Society for Biomaterials.
Articles are welcomed from all scientists. Membership in the Society for Biomaterials is not a prerequisite for submission.